Dr. Neil Paulvin

6.4K posts

Dr. Neil Paulvin banner
Dr. Neil Paulvin

Dr. Neil Paulvin

@NeilpDo

Longevity Physician|Hormones|| Precision Medicine Using Medicine 3.0 to help patients improve their health and optimize performance

New York, NY Katılım Temmuz 2012
4.4K Takip Edilen3K Takipçiler
Dr. Neil Paulvin retweetledi
Science Magazine
Science Magazine@ScienceMagazine·
Traumatic head injuries from collision and combat sports disrupt the blood-brain barrier and trigger inflammation for years after retirement, shows a new MRI and transcriptomic analysis of retired athletes. Find out more in @ScienceTM on #WorldBrainDay: scim.ag/40AguUm
Science Magazine tweet media
English
9
52
166
33.3K
Daniel Wexler
Daniel Wexler@WexlerRules·
Camden Lohman 4 innings 2 hits 0 runs 1 walk 6 k’s 👀 #Mets
English
1
0
7
644
Laura Albanese
Laura Albanese@AlbaneseLaura·
Clay Holmes is scheduled to pitch three innings in a rehab start with Scranton Thursday. He'll most likely need one more after that, Andy Green said.
English
3
2
26
4.3K
Charles Brenner, PhD
Charles Brenner, PhD@CharlesMBrenner·
fyi the reason ppl get hot rx to NAD+ infusions is that NAD+ is an intracellular metabolite—innate immune cells interpret NAD+, mitochondria & chromosomal DNA as signs of cell rupture/infection no one should be doing NAD+ infusions this is _not_ the same as oral or IV Niagen
Mansi@mansizzzzle

A 27 year old woman just died after getting an NAD+ infusion at a sketchy wellness center in the Bronx The "doctor" was an unlicensed quack who's been caught smuggling prescription meds from the Dominican Republic before Way too many grifters in health these days

English
5
6
51
7.2K
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
@ericlitman It’s both. There are too many cooks in the kitchen with different and agendas. We will take a couple steps back and wait for some of the studies to come out
English
0
0
1
21
Eric Litman
Eric Litman@ericlitman·
@NeilpDo Seems the FDA is more concerned with culpability than harm reduction
English
1
0
0
13
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
Looking worse and worse for peptides to be approved
Bijan Salehizadeh@bijans

I really do not understand whats going on behind the scenes before this week’s PCAC meeting on certain peptides Story just published: Pharmacy compounders have withdrawn their nomination of seven peptides for inclusion on FDA’s list of substances that can be compounded in bulk, leaving FDA, which has written a brief opposing the additions, as the only party to formally present evidence when the agency’s newly tapped compounding advisors meet later this week. Most of the new advisors back peptides and the meeting was expected to be the next flashpoint between FDA and MAHA supporters, who may still tout the products in the public comment portion of the meeting. FDA’s Pharmacy Compounding Advisory Committee (PCAC) is set to issue recommendations about whether FDA should allow compounding of the popular peptides, many of which are promoted by influencers adjacent to the “Make America Healthy Again” movement. All seven of the bulk drug substance categories up for consideration at the meeting were originally recommended for inclusion on the 503A Bulks List by Wells Pharmacy Network, the same company that was recently involved in a dispute over state restrictions on pharmacy compounders that reached the Supreme Court. However, Wells Pharmacy later withdrew its recommendations. Two of the substances were additionally recommended for inclusion by LDT Solutions, another compounding firm, which also withdrew its recommendations. FDA says in meeting materials for each of the substances that although the nominations were withdrawn, FDA is considering the nominated peptides “on its own initiative” and will consider the materials submitted by the firms in support of their nominations, including studies of the peptides’ health impacts. The only presentations at the PCAC meeting will now be from FDA, which disclosed in its meeting materials that it will recommend against adding each substances to the bulks list, as well as from speakers who have signed up to share their views. Wells Pharmacy and LDT Solutions did not respond to requests for comment on why they had withdrawn the nominations and whether they would speak at the meeting.

English
1
0
2
200
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
Thank you @BillAckman for putting this much into brain research. This will be so helpful to help prevent brain issues and neurodegenerative illness and not to treat after the fact
Melanie Notkin@SavvyAuntie

Wow @BillAckman you and Neri are truly extraordinary. (And love seeing @hubermanlab is a board member) — Ackman to spend $260 million to create a massive brain research institute The new facility will be constructed on the Upper West Side, where Ackman has just purchased two buildings for a planned 700,000 square foot institute. fortune.com/2026/07/21/per…

English
0
0
6
1.4K
Dr. Neil Paulvin retweetledi
TopSecretStocks 🤫
TopSecretStocks 🤫@topsecretstocks·
$HIMS $ENHA 🚨 South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group, which specializes in peptide-based active pharmaceutical ingredients. 👀 Key Points 👇 > Samsung Biologics has made a 1.46 billion Swiss francs ($1.8 billion) bid for PolyPeptide Group. > With the acquisition, the company will expand its pipeline into peptide therapeutics to tap into the booming weight-loss drug market. > South Korean biologics drugmaker expects to complete the deal by end of the year. You just need to connect the dots here... Peptides are coming for the mass... It's not a matter of if, just when...
TopSecretStocks 🤫 tweet media
English
2
2
46
3.6K
Dr. Neil Paulvin retweetledi
Hims House
Hims House@himshouse·
$HIMS 🚨 BREAKING: FDA ADDS 8 NEW MEMBERS TO PEPTIDES PANEL AFTER FACING CRITICISM THAT THE PANEL WAS "STACKED" WITH PRO-PEPTIDE PEOPLE
Hims House tweet media
English
13
10
221
55.3K
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
@ferrisbuhler81 @DrAlexTatem They are not thinking that way. What will probably result will push those want then to gray market which is worse case scenario someone will get hurt
English
0
0
1
382
Brigham Buhler
Brigham Buhler@ferrisbuhler81·
The FDA is voting on peptide therapy this week. The question isn't whether patients will use these therapies. They will. The question is whether they'll do it with medical oversight, or through the gray market.
English
32
22
264
22.8K
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
@TheMetsX @davidja34279717 @metsarebest2 Plus Thornton. Plus there are some bullpen guys ready to come up . I think you are forgetting santucci, guzman, carreno, chrinos, channing austin , voit, morabito, Snyder and more. So let's temper the negativity
English
0
0
0
32
Unbiased Mets Fan
Unbiased Mets Fan@TheMetsX·
An 18 year old SS with a 739 ops in a ball + awful defense at SS being the 3rd best prospect is massive indictment on the Mets system I get he’s talented, but that’s a tough look
SleeperMets@SleeperMets

.@BaseballAmerica updated Mets top-10 prospect list: 1. Jonah Tong SP 2. Jonathan Santucci SP 3. Elian Pena SS 4. Jacob Reimer 3B 5. Jack Wenninger SP 6. Mitch Voit 2B 7. Ryan Clifford 1B 8. Zac Thornton SP 9. Aidan Robbins OF 10. Nick Morabito OF

English
31
1
37
29.8K
Dr. Neil Paulvin
Dr. Neil Paulvin@NeilpDo·
@WexlerRules @Mets But we already have a shortstop and Pena. Just kidding. After this season we deserve to win the lottery
English
1
0
4
237
Phillip Feliz | Master Flip 🇩🇴
Feel however you want about David Stearns, but the Mets landed the best available starting pitcher on the market last offseason in Freddy Peralta. Peralta was coming off a top 5 Cy Young season, and no other starter who signed or was traded this past winter had a stronger year behind him. So no, it’s not an indictment on the pitching acquisition strategy, but of the collective underwhelming performances across the entire roster.
Laura Albanese@AlbaneseLaura

Freddy Peralta isn't helping to justify Stearns' philosophy on pitching Peralta isn't the same pitcher who dominated for Milwaukee last year, but that's more an indictment of the pitching acquisition strategy that got the Mets here in the first place. newsday.com/sports/columni…

English
46
10
162
30.3K